Skip to main content

Arthroplasties, Knee Replacement

0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Nordic Pharma
Nordic PharmaFrance - Paris
1 program
Depuy total knee implantN/A1 trial
Active Trials
NCT03272178Completed100Est. Nov 2021
Stryker
StrykerCA - San Jose
1 program
Depuy total knee implantN/A
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Inelastic adjustable compression garmentN/A1 trial
Active Trials
NCT06095401Recruiting58Est. Apr 2026
Corin
CorinUK - Cirencester
1 program
Omnibotics Robotic-assisted Total Knee Arthroplasty with Apex UCN/A1 trial
Active Trials
NCT06203756Enrolling By Invitation713Est. Apr 2040

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Colorado TherapeuticsInelastic adjustable compression garment
Nordic PharmaDepuy total knee implant
CorinOmnibotics Robotic-assisted Total Knee Arthroplasty with Apex UC

Clinical Trials (3)

Total enrollment: 871 patients across 3 trials

NCT06095401Colorado TherapeuticsInelastic adjustable compression garment

Swelling Management After Knee Replacement

Start: Feb 2024Est. completion: Apr 202658 patients
N/ARecruiting
NCT03272178Nordic PharmaDepuy total knee implant

Impact of Component Design and Fixation in Total Knee Arthroplasty

Start: Nov 2017Est. completion: Nov 2021100 patients
N/ACompleted
NCT06203756CorinOmnibotics Robotic-assisted Total Knee Arthroplasty with Apex UC

Patient Outcomes With Robotic-Assisted Total Knee Arthroplasty

Start: Nov 2017Est. completion: Apr 2040713 patients
N/AEnrolling By Invitation

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 871 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.